| Determining breast cancer biomarker status and associated morphological features using deep learning P Gamble, R Jaroensri, H Wang, F Tan, M Moran, T Brown, ... Communications medicine 1 (1), 14, 2021 | 87 | 2021 |
| Current and future applications of artificial intelligence in pathology: a clinical perspective EA Rakha, M Toss, S Shiino, P Gamble, R Jaroensri, CH Mermel, ... Journal of clinical pathology 74 (7), 409-414, 2021 | 86 | 2021 |
| Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance M Althobiti, MA Aleskandarany, C Joseph, M Toss, N Mongan, ... Histopathology 73 (6), 887-896, 2018 | 82 | 2018 |
| Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast MS Toss, I Miligy, A Al-Kawaz, M Alsleem, H Khout, PC Rida, R Aneja, ... Modern Pathology 31 (8), 1226-1236, 2018 | 76 | 2018 |
| SlideGraph+: Whole slide image level graphs to predict HER2 status in breast cancer W Lu, M Toss, M Dawood, E Rakha, N Rajpoot, F Minhas Medical Image Analysis 80, 102486, 2022 | 65 | 2022 |
| Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer C Joseph, M Arshad, S Kurozomi, M Althobiti, IM Miligy, S Al-Izzi, MS Toss, ... Breast Cancer Research and Treatment 174, 387-399, 2019 | 61 | 2019 |
| Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer A Katayama, IM Miligy, S Shiino, MS Toss, K Eldib, S Kurozumi, CM Quinn, ... Modern Pathology 34 (7), 1271-1281, 2021 | 58 | 2021 |
| Breast cancer histologic grading using digital microscopy: concordance and outcome association EA Rakha, M Aleskandarani, MS Toss, AR Green, G Ball, IO Ellis, ... Journal of clinical pathology 71 (8), 680-686, 2018 | 54 | 2018 |
| A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk S Klimov, IM Miligy, A Gertych, Y Jiang, MS Toss, P Rida, IO Ellis, A Green, ... Breast Cancer Research 21, 1-19, 2019 | 47 | 2019 |
| The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts M Alsaleem, MS Toss, C Joseph, M Aleskandarany, S Kurozumi, ... Modern Pathology 32 (7), 967-976, 2019 | 45 | 2019 |
| CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy LH Alfarsi, RE Ansari, ML Craze, MS Toss, B Masisi, IO Ellis, EA Rakha, ... Breast cancer research and treatment 178, 535-544, 2019 | 44 | 2019 |
| Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS) MS Toss, IM Miligy, KL Gorringe, A AlKawaz, H Khout, IO Ellis, AR Green, ... British journal of cancer 119 (12), 1518-1526, 2018 | 40 | 2018 |
| Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations N Wahab, IM Miligy, K Dodd, H Sahota, M Toss, W Lu, M Jahanifar, ... The Journal of Pathology: Clinical Research 8 (2), 116-128, 2022 | 36 | 2022 |
| Molecular complexity of lymphovascular invasion: the role of cell migration in breast cancer as a prototype YA Kariri, MA Aleskandarany, C Joseph, S Kurozumi, OJ Mohammed, ... Pathobiology 87 (4), 218-231, 2020 | 36 | 2020 |
| The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer YA Kariri, M Alsaleem, C Joseph, S Alsaeed, A Aljohani, S Shiino, ... Breast Cancer Research and Treatment 185, 293-305, 2021 | 34 | 2021 |
| The prognostic significance of immune microenvironment in breast ductal carcinoma in situ MS Toss, A Abidi, D Lesche, C Joseph, S Mahale, H Saunders, T Kader, ... British journal of cancer 122 (10), 1496-1506, 2020 | 34 | 2020 |
| Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention R Ali, A Al-Kawaz, MS Toss, AR Green, IM Miligy, KA Mesquita, ... Cancer Research 78 (24), 6818-6827, 2018 | 34 | 2018 |
| A novel prognostic two-gene signature for triple negative breast cancer MA Alsaleem, G Ball, MS Toss, S Raafat, M Aleskandarany, C Joseph, ... Modern Pathology 33 (11), 2208-2220, 2020 | 33 | 2020 |
| Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ M Toss, I Miligy, K Gorringe, K Mittal, R Aneja, I Ellis, A Green, E Rakha Journal of Clinical Pathology 73 (2), 76-82, 2020 | 33 | 2020 |
| ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers KA Mesquita, M Alabdullah, M Griffin, MS Toss, TMAA Fatah, A Alblihy, ... Gynecologic oncology 153 (2), 416-424, 2019 | 33 | 2019 |
